Evaluating different methods of Toxoplasma gondii detection in peripheral blood

Abstract

Belfort et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti–Vascular Growth Factor Agents in a Nationwide Study in France

“…1 Ranibizumab (0.5 mg/0.05 mL [Lucentis; Novartis Pharma SAS]), bevacizumab (1.25 mg/ 0.05 mL [Avastin; Roche]), and aflibercept (2 mg/0.05 mL [Eylea; Bayer HealthCare]) have been used for the treatment of several retinal diseases, including exudative age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. 2,3 Triamcinolone acetonide (4 mg/0.1 mL [Kenacort; Bristol-Myers Squibb]) and dexamethasone implant (0.7 mg [Ozurdex; Allergan SAS]) are the 2 corticosteroid agents used in France for the treatment of diabetic macular edema, 4 retinal vein occlusion edema, 5 and noninfectious intermediate or posterior uveitis. 6 Acute endophthalmitis is one of the worst sightthreatening complications after IVTs.…”